1-20 of 25
Clotilde Cangialosi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Carfilzomib-Lenalidomide-Dexamethasone (KRd) Vs. Lenalidomide-Dexamethasone (Rd) in Newly Diagnosed Fit or Intermediate-Fit Multiple Myeloma Patients Not Eligible for Autologous Stem-Cell Transplantation (Phase III EMN20 Trial): Analysis of Sustained Undetectable Minimal Residual Disease (MRD)

Sara Bringhen, Elisabetta Antonioli, Barbara Gamberi, Benedetto Bruno, Daniele Derudas, Patrizia Tosi, Francesca Fazio, Rita Mazza, Sonia Ronconi, Paolo Corradini, Flavia Lotti, Claudia Cellini, Antonietta Pia Falcone, Piero Galieni, Roberto Ria, Angelo Belotti, Donato Mannina, Anna Maria Cafro, Clotilde Cangialosi, Iolanda Donatella Vincelli, Alessandra Lombardo, Alessandra Larocca, Mario Boccadoro, Mattia D'Agostino
Journal: Blood
Blood (2023) 142 (Supplement 1): 205.
https://doi.org/10.1182/blood-2023-177673
Published: 2023
Journal Articles

Impact of Cumulative Dose of Carfilzomib in Combination with Lenalidomide and Desamethasone in Relapsed Refractory Myeloma Patients: A Retrospective Real Life Survey of the Sicilian Myeloma Network

Concetta Conticello, Enrica Antonia Martino, MD, Vittorio Del Fabro, MD, Giuseppe Sapienza, MD, Valeria Calafiore, Bruno Garibaldi, Salvatore Innorcia, Marina Parisi, MD, Emilia Cotzia, Ugo Consoli, MD, Massimo Poidomani, Cinzia Maugeri, Donato Mannina, MD, Vanessa Innao, MD, Maurizio Musso, Clotilde Cangialosi, MD, Stefania Tringali, Melania Carlisi, MD, Giuseppe Salvatore Longo, Alessandra Romano, MDPhD, Francesco Di Raimondo, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 5636.
https://doi.org/10.1182/blood-2018-99-116452
Published: 2018
Journal Articles

Impact of Bortezomib- or Lenalidomide-Based Induction Treatment on High Risk Cytogenetic Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Enrolled in the Gimema-MM-03-05 and EMN01 Trials

Alessandra Larocca, Massimo Offidani, MD, Pellegrino Musto, MD, Francesca Patriarca, MD, Lorenzo De Paoli, MD, Paolo Corradini, MD, Marco Salvini, MD, Clotilde Cangialosi, MD, Tommasina Guglielmelli, MD, Giovannino Ciccone, Fausto Dore, MD, Angelo Belotti, MD, Mattia D'Agostino, MD, Felicetto Ferrara, MD, Daniela Oddolo, Riccardo Centurioni, MD, Fabrizio Ciambelli, MD, Stefano Spada, Donatella Iolanda Vincelli, MD, Michele Cavo, MD, Nicola Giuliani, MD PhD, Alberto Bosi, MD, Concetta Conticello, MD, Roberto Ria, MD, Maria Teresa Petrucci, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 744.
https://doi.org/10.1182/blood.V130.Suppl_1.744.744
Published: 2017
Journal Articles

Superior PFS2 with VTD Vs TD for Newly Diagnosed, Transplant Eligible, Multiple Myeloma (MM) Patients: Updated Analysis of Gimema MMY-3006 Study

Paola Tacchetti, MD, Lucia Pantani, MD, Valerio De Stefano, MD, Elena Zamagni, MD, Jacopo Peccatori, MD, Annalisa Pezzi, Statistician, Catello Califano, MD, Andrea Nozza, MD, Patrizia Tosi, MD, Carolina Terragna, PhD, Fabrizio Ciambelli, MD, Delia Cangini, MD, Piero Galieni, MD, Clotilde Cangialosi, MD, Giovanni De Sabbata, MD, Francesca Elice, MD, Antonio Palumbo, MD, Michele Cavo, MD
Journal: Blood
Blood (2014) 124 (21): 196.
https://doi.org/10.1182/blood.V124.21.196.196
Published: 2014
Journal Articles

Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular Remission Achievement and Loss Are Major Outcome Predictors

Simone Ferrero, Marco Ladetto, Daniela Drandi, Federica Cavallo, Elisa Genuardi, Marina Urbano, Guglielmo Guarona, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, MD, Claudia Crippa, MD, Luca De Rosa, Antonietta Pia Falcone, MD, Mariella Grasso, Tommasina Guglielmelli, Anna Marina Liberati, Francesco Pisani, Patrizia Pregno, Fausto Rossini, MD, Stefania Oliva, Alberto Rocci, Roberto Passera, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 2077.
https://doi.org/10.1182/blood.V122.21.2077.2077
Published: 2013
Journal Articles

Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Sara Bringhen, Davide Rossi, MD, Maide Cavalli, MD, Roberto Ria, MD, Silvia Gentilini, MD, Francesca Patriarca, Chiara Nozzoli, MD, Anna Levi, MD, Tommasina Guglielmelli, MD, Giulia Benevolo, MD, Donatella Vincelli, MD, Luca Baldini, Fortunato Morabito, MD, Mariella Grasso, MD, Roberto Marasca, MD, Manuela Rizzo, MD, Chiara Pautasso, Pharm D, Antonietta Pia Falcone, MD, Daniela Gottardi, MD, Vittorio Montefusco, MD, Caterina Musolino, MD, Clotilde Cangialosi, MD, Giovanna Mansueto, MD, Anna Marina Liberati, MD, Valeria Magarotto, MD, Paola Omedè, PhD, Pellegrino Musto, MD, Maria Teresa Petrucci, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 200.
https://doi.org/10.1182/blood.V120.21.200.200
Published: 2012
Journal Articles

Bortezomib- and Thalidomide-Induced Peripheral Neuropathy (PN) in Multiple Myeloma (MM): Clinical and Molecular Analysis of 474 Patients Treated with Thalidomide-Dexamethasone (TD) or Bortezomib-TD (VTD)

Paola Tacchetti, MD, Carolina Terragna, PhD, Gioacchino Catania, MD, Magda Marcatti, MD, Andrea Nozza, MD, Felicetto Ferrara, MD, Francesco Nobile, MD, Catello Califano, MD, Anna Baraldi, MD, Andrea Gallamini, MD, Pellegrino Musto, MD, Patrizia Tosi, MD, Piero Galieni, MD, Annalisa Pezzi, Statistician, Francesco Lanza, MD, Michela Ceccolini, MD, Filippo Ballerini, MD, Lucio Catalano, MD, Clotilde Cangialosi, MD, Antonio Lazzaro, MD, Giorgio Paladini, MD, Ruggero Mozzana, MD, Beatrice Anna Zannetti, MD, Graziella Pinotti, MD, Francesca Elice, MD, Michele Baccarani, MD, Mario Boccadoro, MD, Guido Cavaletti, MD, Michele Cavo, MD
Journal: Blood
Blood (2011) 118 (21): 1821.
https://doi.org/10.1182/blood.V118.21.1821.1821
Published: 2011
Journal Articles

LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL

Marco Ladetto, MD, Simone Ferrero, Daniela Drandi, PhD, Federica Cavallo, Luigia Monitillo, Paola Ghione, Sara Barbiero, Mariella Grasso, Fausto Rossini, MD, Tommasina Guglielmelli, MD, Clotilde Cangialosi, MD, Anna Marina Liberati, MD, Vincenzo Callea, MD, Tommaso Caravita, MD, Luca De Rosa, MD, Francesco Pisani, Antonietta Pia Falcone, Patrizia Pregno, MD, Alberto Rocci, Roberto Passera, Mario Boccadoro, Antonio Palumbo, MD
Journal: Blood
Blood (2011) 118 (21): 827.
https://doi.org/10.1182/blood.V118.21.827.827
Published: 2011
Journal Articles

Melphalan/Prednisone/Lenalidomide (MPR) Versus High-Dose Melphalan and Autologous Transplantation (MEL200) in Newly Diagnosed Multiple Myeloma (MM) Patients <65 Years: Results of a Randomized Phase III Study

Antonio Palumbo, MD, Federica Cavallo, MD, Izhar Hardan, MD, Barbara Lupo, MD, Valter Redoglia, PhD, Moshe Levin, MD, MS, Paolo Corradini, MD, Sara Pezzatti, MD, Francesca Patriarca, MD, Michele Cavo, MD, Magda Marcatti, MD, Norbert Pescosta, MD, Antonietta Pia Falcone, MD, Roberto Ria, MD, Davide Rossi, Giulia Benevolo, MD, Clotilde Cangialosi, MD, Monica Galli, MD, Lucio Catalano, MD, Anna Baraldi, MD, Angelo Michele Carella, MD, Annamaria Cafro, MD, Agostina Siniscalchi, MD, Claudia Crippa, MD, Sara Grammatico, MD, Maide Cavalli, Tommaso Caravita Di Toritto, MD, Francesco Di Raimondo, MD, Arnon Nagler, Mario Boccadoro, MD
Journal: Blood
Blood (2011) 118 (21): 3069.
https://doi.org/10.1182/blood.V118.21.3069.3069
Published: 2011
Journal Articles

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

Clinical Trials & Observations
Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella Genuardi, Roberto Ria, Silvia Gentili, Francesca Patriarca, Chiara Nozzoli, Anna Levi, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Vincenzo Rizzo, Clotilde Cangialosi, Pellegrino Musto, Luca De Rosa, Anna Marina Liberati, Mariella Grasso, Antonietta P. Falcone, Andrea Evangelista, Michele Cavo, Gianluca Gaidano, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (23): 4745–4753.
https://doi.org/10.1182/blood-2010-07-294983
Published: 2010
Journal Articles

Achievement of Complete Response Is a Strong Prognostic Factor In Elderly Newly Diagnosed Myeloma: Retrospective Analysis of 1175 Patients

Francesca Gay, Alessandra Larocca, P.W. Wijermans, Sara Bringhen, Tommasina Guglielmelli, Martijn R. Schaafsma, Giulia Benevolo, Vincenzo Callea, Luca Baldini, Fortunato Morabito, Mariella Grasso, Giuseppe Torelli, Manuela Rizzo, Monica Galli, Grazia Sanpaolo, Clotilde Cangialosi, Paola Omedè, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 1949.
https://doi.org/10.1182/blood.V116.21.1949.1949
Published: 2010
Journal Articles

Melphalan 200 mg/m 2 versus melphalan 100 mg/m 2 in newly diagnosed myeloma patients: a prospective, multicenter phase 3 study

Clinical Trials & Observations
Antonio Palumbo, Sara Bringhen, Benedetto Bruno, Antonietta Pia Falcone, Anna Marina Liberati, Mariella Grasso, Roberto Ria, Francesco Pisani, Clotilde Cangialosi, Tommaso Caravita, Anna Levi, Giovanna Meloni, Andrea Nozza, Patrizia Pregno, Attilio Gabbas, Vincenzo Callea, Manuela Rizzo, Luciana Annino, Valerio De Stefano, Pellegrino Musto, Ileana Baldi, Federica Cavallo, Maria Teresa Petrucci, Massimo Massaia, Mario Boccadoro
Journal: Blood
Blood (2010) 115 (10): 1873–1879.
https://doi.org/10.1182/blood-2009-09-241737
Published: 2010
Journal Articles

MPT Vs ThaDD in Very Elderly Patients with Multiple Myeloma: a Case-Match Study.

Massimo Offidani, Sara Bringhen, Laura Corvatta, Maria Teresa Petrucci, Silvia Gentili, Pellegrino Musto, Claudia Polloni, Fabiana Gentilini, Antonietta Falcone, Tommaso Caravita, Anna Marina Liberati, Marino Brunori, Vincenzo Callea, Eugenio Piro, Mariella Grasso, Clotilde Cangialosi, Piero Galieni, Fausto Rossini, Monica Galli, Marco Montanaro, Francesco Alesiani, Valerio De Stefano, Massimo Catarini, Francesca Elice, Renato Zambello, Giuseppe Visani, Luciano Griso, Emanuele Angelucci, Mario Boccadoro, Pietro Leoni, Antonio Palumbo
Journal: Blood
Blood (2009) 114 (22): 1835.
https://doi.org/10.1182/blood.V114.22.1835.1835
Published: 2009
Journal Articles

Sequential Approach with Bortezomib as Induction Before Autologous Transplantation, Followed by Lenalidomide as Consolidation-Maintenance in Untreated Multiple Myeloma Patients.

Francesca Gay, MD, Patrizia Falco, MD, Claudia Crippa, MD, Anna Marina Liberati, MD, Francesca Patriarca, MD, Clotilde Cangialosi, MD, Vincenzo Capparella, MD, Agostina Siniscalchi, MD, Manuela Rizzo, MD, Luca De Rosa, MD, Antonietta Pia Falcone, MD, Simona Caltagirone, PhD, Sara Bringhen, MD, Paolo Corradini, MD, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2009) 114 (22): 3419.
https://doi.org/10.1182/blood.V114.22.3419.3419
Published: 2009
Journal Articles

Correlation Between Clinical Outcome and Disease Kinetics by Quantitative PCR in Myeloma Patients Following Post-Transplant Consolidation with Bortezomib, Thalidomide and Dexamethasone.

Marco Ladetto, Gloria Pagliano, Simone Ferrero, Federica Cavallo, Daniela Drandi, Michela Boi, Loredana Santo, Claudia Crippa, MD, Luca De Rosa, Patrizia Pregno, Mariella Grasso, Anna Marina Liberati, Tommaso Caravita, Francesco Pisani, Tommasina Guglielmelli, Vincenzo Callea, Fausto Rossini, Pellegrino Musto, Clotilde Cangialosi, Alberto Rocci, Roberto Passera, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2009) 114 (22): 960.
https://doi.org/10.1182/blood.V114.22.960.960
Published: 2009
Journal Articles

Incidence of Febrile Episodes During Stem Cells Mobilization After High Dose Cyclophosphamide Chemotherapy and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma Patients: Preliminary Final Results.

Enrico Orciuolo, Gabriele Buda, Emerenziana Marturano, Elisa Mauro, Giuseppe Milone, Clotilde Cangialosi, Nicola Di Renzo, Domenico Pastore, Marino Brunori, Maria Pia Petrilli, Sergio Storti, Giuseppe Pietrantuono, Patrizio Mazza, Mario Petrini
Journal: Blood
Blood (2009) 114 (22): 4560.
https://doi.org/10.1182/blood.V114.22.4560.4560
Published: 2009
Journal Articles

Bortezomib, Melphalan, Prednisone and Thalidomide (VMPT) Followed by Maintenance with Bortezomib and Thalidomide for Initial Treatment of Elderly Multiple Myeloma Patients.

Antonio Palumbo, Sara Bringhen, Davide Rossi, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Anna Levi, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Barbara Olivero, Fortunato Morabito, Mariella Grasso, Roberto Marasca, Manuela Rizzo, Antonietta Pia Falcone, Daniela Gottardi, Vittorio Montefusco, Caterina Musolino, Renato Zambello, Clotilde Cangialosi, Giuseppe Pietrantuono, Valeria Magarotto, Maria Teresa Petrucci, Pellegrino Musto, Giovannino Ciccone, Francesco Di Raimondo, Gianluca Gaidano, Mario Boccadoro
Journal: Blood
Blood (2009) 114 (22): 128.
https://doi.org/10.1182/blood.V114.22.128.128
Published: 2009
Journal Articles

Incidence of Febrile Episode During Stem Cell Mobilization (SCM) After High Dose Ciclophosphamide Chemotherapy (HD-CTX) and G-CSF (filgrastim or lenograstim) Administration in Multiple Myeloma (MM) Patients: II Interim Evaluation

Enrico Orciuolo, Gabriele Buda, E. Mauro, E. Marturano, Domenico Pastore, Paola Della Cioppa, Giuseppe Pietrantuono, Letizia Lombardini, Nicola Di Renzo, MD, Giuseppe Irrera, MD, Clotilde Cangialosi, Marino Brunori, Mario Petrini, MD
Journal: Blood
Blood (2008) 112 (11): 4135.
https://doi.org/10.1182/blood.V112.11.4135.4135
Published: 2008
Journal Articles

Melphalan 200 Mg/m 2 (Mel200) Versus Melphalan 100 Mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients: A Prospective, Randomized Phase III Study

Mario Boccadoro, MD, Sara Bringhen, MD, Maria Teresa Petrucci, MD, Antonietta Falcone, MD, Anna Marina Liberati, MD, Roberto Ria, MD, Mariella Grasso, MD, Marco Montanaro, MD, Patrizia Pregno, MD, Andrea Nozza, MD, Francesco Pisani, MD, Tommaso Caravita, MD, Clotilde Cangialosi, MD, Elisabetta Calabrese, MD, Alessandra Larocca, MD, Federica Cavallo, MD, Marina Ruggeri, PhD, Pellegrino Musto, MD, Robert Foà, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2008) 112 (11): 3316.
https://doi.org/10.1182/blood.V112.11.3316.3316
Published: 2008
Journal Articles

A Prospective, Randomized, Phase III Study of Melphalan 200 mg/m 2 (Mel200) Versus Melphalan 100 mg/m 2 (Mel100) in Newly Diagnosed Myeloma Patients.

Antonio Palumbo, MD, Sara Bringhen, MD, Maria Teresa Petrucci, MD, Antonietta Falcone, MD, Anna Marina Liberati, MD, Vito Michele Lauta, MD, Mariella Grasso, MD, Marco Montanaro, MD, Francesco Pisani, MD, Tommaso Caravita, MD, Clotilde Cangialosi, MD, Patrizia Pregno, MD, Andrea Nozza, MD, Elisabetta Calabrese, MD, Francesca Gay, MD, Federica Cavallo, MD, Paola Omedè, BSc, Pellegrino Musto, MD, Robin Foà, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2007) 110 (11): 727.
https://doi.org/10.1182/blood.V110.11.727.727
Published: 2007